Weight-Loss Drugmakers Lobby for Medicare Coverage

[ad_1] Adding Ozempic and Mounjaro to federal plans, whose prescription benefit excludes weight drugs, could stoke sales. [ad_2] Source link

Hype Around Weight-Loss Drugs Shows No Signs of Abating. Neither Do the Ads.

[ad_1] Ads for the likes of Ozempic and Wegovy are spreading through social media feeds, subway stations and TV. [ad_2] Source link

Novo Nordisk Is Raising the Bar on Diabetes, Obesity Drugs — Analysis

[ad_1] Novo Nordisk is currently relaunching its diabetes drug Wegovy in the U.S., with rising capacity putting the company in a solid position to boost growth, according to analysts. [ad_2]…

Americans to Be Barred From Buying Ozempic in British Columbia

[ad_1] Provincial health officials urged doctors and pharmacists to make sure people are taking the drug to treat diabetes, not lose weight. [ad_2] Source link

Eli Lilly Is Priced for Perfection in the Obesity Market

[ad_1] The company has outperformed its pharma peers in recent years, but its valuation leaves little room for error. [ad_2] Source link

New Diabetes Drugs Like Ozempic Are Changing How Patients Are Treated

[ad_1] Health After years recommending generic drug metformin, American Diabetes Association says doctors could give a newer medicine first [ad_2] Source link

Why Obesity-Drug Makers Just Lost Weight

[ad_1] Markets Heard on the Street Novo Nordisk and Eli Lilly are working to ramp up capacity, insurance coverage [ad_2] Source link

U.S. Appeals Court Sides With Drugmakers on Discount Program

[ad_1] Business Health Care Health Drugmakers can limit shipments to hospitals and clinics of drugs discounted under federal program, court rules in loss for hospitals [ad_2] Source link